EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Abstracts

Indian Journal of Cardiology · 2025

DOI: 10.4103/ijoc.ijoc_12_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indian Journal of Cardiology, 2025. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitieren

Abstract (Originalsprache)

No. 1: Aortic Measurements in South Indian Population Arulanandhan Ettiyan, Kannan Radhakrishnan, Raghothaman Sethumadhavan, Sureshkumar Ponnuswamy Department of Cardiology, Government Chengalpattu Medical College and Hospital, Chengalpattu, Tamil Nadu, India E-mail: [email protected], [email protected], [email protected], [email protected]

Introduction

Benchmark for normal size measurements of the aortic annulus, Sinus Of Valsalva and ascending aorta is usually from the western literature. The size of the valve used for TAVR is manufactured based on the western population. Also, to determine when to intervene surgically in patients who have an aortic aneurysm, is also based on western literature. The body surface area of Indian patients is smaller than the Western population. So, using the same parameters may not be advisable in Indian patients. Hence the need for assessing the normal aortic root and annulus size in Indian patients has become paramount. Aim of the Study: To assess the size of aortic annulus, sinus of Valsalva, sino-tubular junction and ascending aorta in normal South Indian patients among varied age groups, different body surface area & among both sexes. Inclusion Criteria: Normal population who came for echo to Chengalpattu Medical College, Age group 10 – 80 years. Both sexes, Patients with varying body surface area and BMI. Exclusion Criteria: Patients with structural heart disease, Systemic hypertension, Coronary artery disease, Heart failure Valvular heart disease, Chronic kidney disease. Patients with poor echo window.

Methods

Nearly 2500 patients who visited the Department of Cardiology at Chengalpattu Medical College were included in the study, The study period was 6 months from October 2023 to March 2024. 1000 patients were excluded from the study based on the exclusion criteria mentioned earlier, The aortic annulus, sinus of Valsalva, sino-tubular junction and ascending aorta were measured in cms in a standard parasternal long axis view in 2D echocardiography at the sites mentioned in standard literature and the results were noted, The results obtained were divided based on sex, age and body surface areas.

Discussion

As in the Western population, as the age progresses, our study also showed that the size of the aortic annulus, SOV, sino-tubular junction and ascending aorta increases with age. Also, as in the Western study, the size of the above four values were more in males than in females. When compared with the Western studies, our study showed that among age & sex matched individuals, such sizes were smaller in our Indian patients compared to the Western population.

Conclusion

Indian patients have a smaller body surface area compared to Western population. Their aortic size is also substantially smaller than their Western counterparts. This gap is even more evident in female population. The valves which are manufactured for TAVR procedure are based on the normal Western values. We need to develop smaller valves which would suit our Indian patients. Also, the cut-off criteria for surgical intervention for aortic aneurysm and Bentall procedure needs to be tailored to Indian population and need to be lower than the values mentioned in the Western literature.Abstract No. 2: A Study on Quality Assessment of Type 2 Diabetes Mellitus Care in Patients Presenting with Acute Coronary Syndrome and/or Heart Failure Gurumayum Ramcharan Sharma, Manoj Ravi, T. Govindan Unni Department of Cardiology, JMMC and RI, Thrissur, Kerala, India Background: European Society of Cardiology 2019 guideline has listed the major targets listed for cardiovascular disease prevention in diabetic patient.[1]

Aim

To measure and inquire quality of T2DM care in in patients presenting with first episode of ACS and/or HF in terms of guideline directed goals of glycemic control, blood pressure control, blood cholesterol control, BMI and smoking habits.[1,2] Methodology: It was a prospective cross sectional observational study conducted from January 2023 to June 2024 at a tertiary care center. Sample size was calculated to be 77.[3] Results and Discussion: In the study, 88.3% were male. Mean age was 56.4 yrs±9.9 yrs(σ) which was comparable to Indian studies i.e. MERIFACS[4] & INTERHEART STUDY.[5] However almost a decade earlier than the other Asiatic populations (e.g. Koshizaka et al.[6]). Mean HbA1c was 9.5% with range of 5.9% to 13.8%. HbA1c was ≥7% in 92.2% of the patients. Blood pressures were not controlled in 40.3% of the enrolment which was comparable to other Indian studies MERIFACS[4] & INTERHEART[5] studies. Mean LDL level was 127 mg/dl ± 33.9 mg/dl(σ) compared with 120 mg/dl±36.6 mg/dl(σ) in MERIFACS.[4] LDL was ≥100 mg/dl in 77.9% of the patients against 70.2% in MERIFACS.[4] Median ASCVD risk score was 16.1% (IQR 8.5%-27.3%). 79.2% of the patients were not on statin. Only 2.6 % was on moderate intensity statin and 18.2% on low intensity statin despite the recommendation of minimum moderate intensity statin. In a Korean study by Park et al.,[7] 84.8% of the patients were on statin. BMI were not controlled with ≥ 23 kg/m2 in 64.9% of the patients. In MERIFACS,[4] mean BMI was 25.21 kg/m2 ± 4.1 kg/m2(σ) compared with 24.1 kg/m2 ± 3.7 kg/m2(σ) in our current study. Former smoker formed 18%, and 10.4% of the patient were currently smoking. In comparison, Koshizaka et al.[6] reported, among Asian patients 25.3% to be current smoker, 28.3% in MERIFACS[4] study and 45.17% in INTERHEART.[5]

Conclusion

The study demonstrates that primary prevention in DM is far below the guideline directed levels with respect to HbA1C, Blood Pressure control, LDL cholesterol, statin treatment and BMI values. References 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:S62-9. Goldberg RB. Cardiovascular disease in diabetic patients. Med Clin North Am 2000;84:81-93, viii. Hygriv Rao B, Rama Raju NS, Srinivasa Raju CS, Patel P, Korabathina R, Raj JP, et al. Metabolic risk factors in first acute coronary syndrome (MERIFACS) study. Indian Heart J 2022;74:275-81. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004;364:937-52. Koshizaka M, Lopes RD, Newby LK, Clare RM, Schulte PJ, Tricoci P, et al. Obesity, diabetes, and acute coronary syndrome: Differences between Asians and whites. Am J Med 2017;130:1170-6. Park SJ, Ha KH, Kim DJ. Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: The obesity paradox in a Korean national cohort study. Cardiovasc Diabetol 2020;19:191. Abstract No. 3: Left Ventricular Global Longitudinal Strain and Left Atrial Strain after Dual Chamber Permanent Pacemaker Implantation Vivek Thapa, N. Jayaprasad Department of Cardiology, Government Medical College, Kottayam, Kerala, India Background: Chronic right ventricular pacing is associated with electrical and mechanical dys-synchrony which can lead to deleterious effects on cardiac function. Some studies have shown that left ventricular global longitudinal strain can predict the development of pacemaker induced ventricular dysfunction or pacemaker induced cardiomyopathy before any appreciable decrease in left ventricular ejection fraction develops. Left atrial strain has also been shown to be a potential predictor of new onset atrial fibrillation after pacemaker implantation.

Aims

1. To determine the changes in left ventricular and left atrial strain after dual chamber permanent pacemaker implantation 2. To correlate changes in left ventricular and left atrial strain with the development of pacemaker induced ventricular dysfunction/cardiomyopathy and new onset atrial fibrillation.

Methods

We studied 40 patients who met study criteria over 1 year with left ventricular ejection fraction ≥50% undergoing dual chamber permanent pacemaker implantation. Echocardiographic assessments of cardiac structure and function were done at baseline and at one month and six months of follow up.

Results

Our study involved 40 patients of which 47.5% were males and 52.5% were females. Mean age was 62.78 years. Indication for pacing was second degree AV block in 22.5%, third degree AV block in 50% and sinus node dysfunction in 27.5%. At 6 months of follow up, PIVD was noted in 20% and PICMP was noted in 10% patients. All patients (100%) in PIVD/PICMP group had RV apical site of pacing. Whereas in normal LVEF group, 75% had RV apical pacing and 25% had RV septal pacing. There was a trend towards lower incidence of PIVD/PICMP in patients with RV septal pacing. However, this difference was not statistically significant (p=0.056). The ventricular pacing percentage was significantly higher in PIVD/PICMP group as compared to normal LVEF group (p 16) when compared to the low risk group (MRS 16) was substantially higher in our study (77.8 %) as compared to same group in Mehran study (57.3 %).

Conclusion

The study demonstrates Predictability of Mehran risk score for contrast induced nephropathy is pertinent even in Indian population. Very high risk groups (MRS > 16) have a substantially higher incidence of contrast induced nephropathy in Indian population as compared to western population, but the difference may be because of the less sample size in very high risk group in our study compared to the Mehran study Periprocedural hypotension, anemia, congestive heart failure and baseline eGFR were significant predictors of contrast induced nephropathy Contrast induced nephropathy was associated with requirement of renal replacement therapy. MEHRAN RISK SCORE holds potential value in assessing and predicting the contrast induced nephropathy. Abstract No. 6: Correlation of Hematological Indicis and Timi Flow in ST Elevation Myocardial Infarction Patients Undergoing B. R. Manju Bhargav1, K. Sivaprasad2 1Government Medical College, Thiruvananthapuram, Kerala, India, 2Department of Cardiology, Government Medical College, Thiruvananthapuram, Kerala, India Background: ST-Elevation Myocardial Infarction (STEMI) is a type of Acute coronary syndrome (ACS) characterized by persistent ST-segment elevation in ECG and increased cardiac biomarkers caused by total occlusion of the culprit coronary artery with a thrombus due to atherosclerotic plaque rupture. Primary percutaneous coronary intervention (PCI) is the preferred treatment for patients with STEMI because it reduces short and long-term morbidities and death rates during follow-up. Thrombolysis In Myocardial Infarction (TIMI) flow grade helps assess the prognosis of Primary PCI in STEMI patients. Coronary artery flow is categorized into four grades: grade 0 (no flow), grade 1 (penetration without perfusion), grade 2 (partial perfusion), and grade 3 (complete perfusion). Patients with STEMI had significantly more short-and intermediate-term adverse cardiac events when their post-PCI TIMI flow grades were two or less. Thrombosis, atherogenesis, and inflammation play significant roles in the pathophysiology of ACS. White blood cells (WBCs) play a role in STEMI pathogenesis, destabilising and rupturing plaques, leading to thrombotic events. Increased WBC count at admission could be a significant prognostic factor for adverse outcomes and death in STEMI patients. Platelet involvement in atherothrombosis leads to ACSs, and patients with elevated platelet counts have a higher risk of inflammation and unfavourable consequences. This study evaluates the association of haematological indices, including red blood cell, platelet, and white blood cell indices, to TIMI flow after Primary PCI.

Objectives

Primary Objective: To correlate the association of haematological indices before Primary PCI (Percutaneous Coronary Intervention) with the TIMI flow (Thrombolysis in Myocardial Infarction) after Primary PCI. Secondary Objective: To correlate TIMI flow (Thrombolysis in Myocardial Infarction) and Hematological indices to Major Adverse cardiovascular events of STEMI (ST-Elevation Myocardial Infarction) patients at 30-day follow-up.

Methods

The prospective observational study included STEMI patients admitted for Primary PCI in the Department of Cardiology, Government Medical College, Thiruvananthapuram. Then, participants were divided into three groups based on their post-procedural TIMI flow grades. Before performing Primary PCI, we collected the patients’ demographic data and hematologic indices and evaluated their association with the TIMI grade flow after Primary PCI. To compare the quantitative and qualitative variables, chisquare and t-tests were performed, respectively.

Results

In this study, 21% of the participants showed the coronary slow flow phenomenon (TIMI grade less than 2). Lower levels of haemoglobin, RBC count, and higher levels of PCV, platelet count, MPV, and PDW were associated with slow coronary flow. All these factors showed a strong correlation with TIMI flow grade. Although some indices like RDW, WBC, and PLR not a with TIMI flow. The haematological factors were also to predict Major Adverse Cardiovascular after Primary Percutaneous Coronary Intervention and factors such as RBC count, RDW, Platelet count, and had a strong correlation with heart and after Primary PCI.

Conclusion

It is to assess haematological indices such as RBC count, PCV, RDW, platelet count, MPV, and PLR before performing primary PCI, as these are This may help STEMI patients undergoing primary PCI. It can also in the coronary slow flow phenomenon and predict the of major adverse cardiac events after primary PCI. Coronary slow haematological indices, major adverse cardiovascular primary percutaneous coronary myocardial in myocardial infarction flow

Zitieren

APA

(2025). Abstracts. Indian Journal of Cardiology. https://doi.org/10.4103/ijoc.ijoc_12_25

Vancouver

Abstracts. Indian Journal of Cardiology. 2025. doi:10.4103/ijoc.ijoc_12_25

BibTeX
@article{euvimed2025,
  title = {Abstracts},
  journal = {Indian Journal of Cardiology},
  year = {2025},
  doi = {10.4103/ijoc.ijoc_12_25}
}
Kostenlos starten →